Skip to main content
OMER logo

Omeros Corporation

OMERNASDAQHealthcareBiotechnology

$16.20Today:- (-)1Y +131.83%

As of Oct 16, 2026 close

Market cap
$1.68B
P/E (TTM)
6.95
Forward P/E
-
Dividend yield
-
52-week range
$6.24$21.24
Volume (live)
-
Avg. volume (3M)
1.39M

Omeros (OMER) Stock Price & Financial Analysis

Omeros Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$15.85 - $17.94
52-Week High$21.24
52-Week Low$6.24
Open$17.94
Volume (last close)3.96M
Average Volume (3M)1.39M
Earnings & Profitability
Revenue (TTM)38.42M
Net Income (TTM)242.19M
Free Cash Flow (TTM)-330.00M
EPS (TTM)$2.92
Profit Margin630.35%
Operating Margin-196.53%
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap1.68B
Shares Outstanding89.63M
P/E Ratio (TTM)6.95
Price to Sales (P/S)43.83
Price to Book (P/B)-32.80
EV/EBITDA15.91
Technical Indicators
50-Day MA$18.11
200-Day MA$13.33
1-Year Change+131.83%

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare OMER with other stocks

Omeros at a Glance

As of the Oct 16, 2026 close, Omeros (OMER) has a market capitalization of $1.68B. The stock trades at 7.0× trailing earnings and 43.8× sales. Over the trailing twelve months it earned $242.19M on revenue of $38.42M (a 630.4% profit margin) and burned $330.00M of free cash flow.

As of its latest reported balance sheet, it holds $1.99M in cash and securities against $83.77M of debt, a net debt position of $81.78M.

Omeros does not currently pay a dividend.

The share price is up 131.8% over the past year. At $16.20 (the Oct 16, 2026 close) it sits within its 52-week range of $6.24 to $21.24, above its 200-day moving average of $13.33.

Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.

Frequently Asked Questions About Omeros

What is the current stock price for OMER?

As of the Oct 16, 2026 close, OMER stock trades at $16.20. The 52-week range is $6.24–$21.24, with a day range of $15.85–$17.94.

What is the P/E ratio for OMER?

As of the Oct 16, 2026 close, Omeros's trailing twelve-month (TTM) P/E ratio is 7.0, meaning investors pay $7.0 for every $1 of annual earnings. Omeros operates in the Healthcare sector.

Does OMER pay dividends?

Omeros does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for OMER?

Based on ratings from 1 professional analyst over the last 90 days, the consensus for OMER is Buy.

What is the market cap of OMER?

As of the Oct 16, 2026 close, Omeros's market capitalization is $1.45B, classifying it as a small-cap company. Omeros operates in the Healthcare sector within the Biotechnology industry.